Neil V. Harris

Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes

Jon M. Sutton, David E. Clark, Stephen J. Dunsdon et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 68 citations · Full text

Diabetes Management, Biochemistry, Medicine +8

Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines

Neil V. Harris, Christopher Smith, Keith Bowden · Journal of Medicinal Chemistry · 1990 · 43 citations

Selective ET_AAntagonists. 5. Discovery and Structure−Activity Relationships of Phenoxyphenylacetic Acid Derivatives

Peter C. Astles, Thomas J. Brown, Frank Halley et al. · Journal of Medicinal Chemistry · 2000 · 40 citations · Full text

Receptor Antagonist, Organic Chemistry, Pharmacotherapy +16

Acyl-CoA: cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT

Neil V. Harris, Andrew W. Bridge, Raymond C. Bush et al. · Journal of Medicinal Chemistry · 1992 · 38 citations · Full text

Mevalonate Derivative 2, Pharmacotherapy, Low Density +19

Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol

David Riddell, Colin Bright, Brenda J. Burton et al. · Biochemical Pharmacology · 1996 · 34 citations

Hypolipidaemic Properties, Oxysterol, Biochemistry +7